10 Pathways for Novel Antibiotic Development in 2026
Artificial Intelligence in De Novo Molecular Design In 2026, novel antibiotic development is being accelerated by AI platforms that can design molecules from scratch. These systems simulate the interaction between potential antibacterial drugs and bacterial targets at an atomic level, identifying candidates that are unlikely to trigger resistance. This computational approach has shortened the...
0 Kommentare 0 Geteilt 179 Ansichten 0 Bewertungen